Current Concepts in the Management of VHL
Pathophysiology and management of Von Hippel-Lindau syndromeПодробнее
Von Hippel-Lindau Disease: Neurologic and Otologic Manifestations - Dr MehtaПодробнее
VHL Breakthrough: An Expert DiscussionПодробнее
Clinical Management of VHL Tumors - Systemic Agents for VHL | Medical Symposium 2024Подробнее
]New Genomic Data on the Management of VHL-Mutated Clear Cell RCCПодробнее
![]New Genomic Data on the Management of VHL-Mutated Clear Cell RCC](https://img.youtube.com/vi/N_U2JMVJyBQ/0.jpg)
Von Hippel-Lindau Disease: Clinical Update and New Drug TherapyПодробнее
Systemic Therapy for Von Hippel-Lindau Associated Tumors | Ramaprasad Srinivasan, MD, PhDПодробнее
Von Hippel-Lindau Disease Management: Expert Insights | Dr. Eric Jonasch | CME ActivityПодробнее
Current Treatment Options for VHL DiseaseПодробнее
Belzutifan for VHL-Associated Tumors: A Molecules to Medicine Success Story—Elaine T. Lam, MD, FACPПодробнее
Keynote: VHL: Gene to Pathway to Precision Management to Therapy | W. Marston Linehan, MDПодробнее
Von Hippel-Lindau Disease: Clinical Update and New Drug TherapyПодробнее
Current Management of Primary Brain TumorsПодробнее
A Webinar Sneak Peek: Von Hippel-Lindau Disease Treatment Advances With Eric Jonasch, MDПодробнее
"von Hippel-Lindau Disease", a scientific lecture by Nobel Laureate William G. KaelinПодробнее
Treatment strategies for Von Hippel-Lindau syndromeПодробнее
Natural History and Treatment of Hemangioblastomas in VHL | Othon Iliopoulos, MD, PhDПодробнее
Special Lecture - VHL 1984-2024: Evolution of Diagnosis, Management, Surgery and TherapyПодробнее
Advances in VHL Disease: Insights from Recent Research with Othon Iliopoulos, MD, PhD | Nov 2024Подробнее
